Advances in Nanomedicine for Cancer Theranostics

Area of Science:

• Nanomedicine
• Cancer Theranostics
• Precision Oncology

Background:

• Cancer remains a leading global cause of mortality, with 19.3 million cases and 10 million deaths in 2020.
• Conventional cancer therapies face limitations in early detection and treatment effectiveness, impacting patient prognosis.
• Nanomedicine presents novel solutions for cancer theranostics, leveraging unique properties like tumor targeting and biocompatibility.

Discussion:

• This Focus Issue explores cutting-edge nanomedicine applications in cancer care.
• Key areas include drug and gene delivery, advanced bioimaging, and biomarker identification.
• The collection also covers diagnostic tools, immunotherapy, biosensors, and precision oncology strategies.

Key Insights:

• Nanomedicine enhances tumor targeting via the enhanced permeability and retention (EPR) effect.
• The small size and biocompatibility of nanomaterials are crucial for effective cancer theranostics.
• Research encompasses a wide range of nanomedicine-based therapeutic and diagnostic approaches.

Outlook:

• This collection features 18 research articles and 11 review articles from leading experts.
• Future directions emphasize the integration of nanomedicine for improved cancer patient outcomes.
• Continued advancements in nanomedicine promise to revolutionize cancer diagnosis and treatment.